(Q34417113)

2 August 2017

Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics (English)

1 reference

2 August 2017

essential hypertension

1 reference

1 reference

Donnelly R

1

1 reference

2 August 2017

Elliott HL

series ordinal

2

1 reference

2 August 2017

Meredith PA

series ordinal

3

1 reference

2 August 2017

Reid JL

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 1987

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

24

1 reference

2 August 2017

5

1 reference

2 August 2017

599-606

1 reference

Review of the role of the central serotonergic neuronal system in blood pressure regulation

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Mechanism of antihypertensive action of ketanserin in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Hemodynamic response to chronic ketanserin treatment in essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1987.TB03218.X

Long-term effects on central haemodynamics and body fluid volumes of ketanserin in essential hypertension studies at rest and during dynamic exercise.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Analysis of the pressor dose response.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386331

Ketanserin and alpha 1-adrenergic antagonism in humans

27 October 2018

1 reference

12 December 2020

Antihypertensive properties of ketanserin in combination with beta-adrenergic blocking agents

1 reference

12 December 2020

Effect of ketanserin on the in vitro regulation of aldosterone

1 reference

12 December 2020

Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients

1 reference

12 December 2020

Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol

1 reference

12 December 2020

Pharmacokinetics of ketanserin in patients with essential hypertension

1 reference

12 December 2020

The variable arterial pressure response to serotonin in laboratory animals and man

1 reference

12 December 2020

Simplified Radioimmunoassay for Serum Aldosterone Utilizing Increased Antibody Specificity

1 reference

12 December 2020

Prazosin determination by high-pressure liquid chromatography using flourescence detection

1 reference

12 December 2020

Role of plasma kallikrein in the proteolytic activation of the renin-angiotensin system

1 reference

12 December 2020

The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension

1 reference

12 December 2020

Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468)

1 reference

12 December 2020

Polymorphous ventricular tachycardia associated with normal and long Q-T intervals

1 reference

12 December 2020

High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine

1 reference

12 December 2020

Ketanserin in essential hypertension: effects during rest and exercise

1 reference

12 December 2020

Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf

1 reference

12 December 2020

Bioavailability and pharmacokinetics of ketanserin in elderly subjects

1 reference

12 December 2020

10.1111/J.1365-2125.1987.TB03218.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference